Bicalutamide 150 mg: Practical prescribing in patients with early prostate cancer

被引：2
|
作者：
Anderson, J [1 ]
机构：
[1] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
BJU INTERNATIONAL | 2004年 / 94卷 / 06期
关键词：
D O I：
10.1111/j.1464-410X.2004.05066.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 50 条
  • [31] Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer
    Sieber, PR
    Keiller, DL
    Kahnoski, RJ
    Gallo, J
    McFadden, S
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2272 - 2276
  • [32] Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up
    M Wirth
    C Tyrrell
    K Delaere
    M Sánchez-Chapado
    J Ramon
    D M A Wallace
    J Hetherington
    F Pina
    C F Heyns
    S Navani
    J Armstrong
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 87 - 93
  • [33] Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer:: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up
    Wirth, M.
    Tyrrell, C.
    Delaere, K.
    Sanchez-Chapado, M.
    Ramon, J.
    Wallace, D. M. A.
    Hetherington, J.
    Pina, F.
    Heyns, C. F.
    Navani, S.
    Armstrong, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2007, 10 (01) : 87 - 93
  • [34] Adjuvant therapy with bicalutamide 150 mg versus standard care alone: Third analysis results from trial 24 of the early prostate cancer programme
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 251 - 251
  • [35] Adjuvant hormonal treatment for prostate cancer: The Bicalutamide Early Prostate Cancer Program
    Wirth, MP
    Froehner, M
    ONCOLOGY, 2003, 65 : 1 - 4
  • [36] Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg
    Scattoni, Vincenzo
    Montironi, Rodolfo
    Mazzucchelli, Roberta
    Freschi, Massimo
    Nava, Luciano
    Losa, Andrea
    Terrone, Carlo
    Scarpa, Roberto M.
    Montorsi, Francesco
    Pappagallo, Giovanni
    Rigatti, Patrizio
    BJU INTERNATIONAL, 2006, 98 (01) : 54 - 58
  • [37] The third analysis of the bicalutamide early prostate cancer programme
    Iversen, P
    BJU INTERNATIONAL, 2006, 97 (03) : 438 - 439
  • [38] Randomised comparison of 'Casodex'™ (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer
    Tyrrell, CJ
    Kaisary, AV
    Iversen, P
    Anderson, JB
    Baert, L
    Tammela, T
    Chamberlain, M
    Webster, A
    Blackledge, G
    EUROPEAN UROLOGY, 1998, 33 (05) : 447 - 456
  • [39] Bicalutamide monotherapy for early stage prostate cancer: An update
    Iversen, P
    JOURNAL OF UROLOGY, 2003, 170 (06): : S48 - S52
  • [40] Bicalutamide for Prostate Cancer
    Tree, Alison
    Grif, Clare
    Hall, Emma
    Dearnaley, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (02): : 469 - 470
12345